These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15322583)

  • 1. Delta-S entropy variation system: a novel biophysical approach to treat chronic-degenerative processes. The challenge of liver cirrhosis.
    Marineo G; Marotta F
    Saudi Med J; 2004 Aug; 25(8):979-82. PubMed ID: 15322583
    [No Abstract]   [Full Text] [Related]  

  • 2. Biophysics and clinical practice for regenerative processes in cirrhosis of the liver/of liver cirrhosis assisted by Delta-S Entropy Variation Systems.
    Marineo G; Fesce E
    Minerva Gastroenterol Dietol; 2006 Dec; 52(4):365-70. PubMed ID: 17108866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history and predictors of disease severity in chronic hepatitis C.
    Massard J; Ratziu V; Thabut D; Moussalli J; Lebray P; Benhamou Y; Poynard T
    J Hepatol; 2006; 44(1 Suppl):S19-24. PubMed ID: 16356583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of liver fibrosis in young blood donors infected with hepatitis C virus: different predictive factors?
    Vadan R; Gheorghe L
    Rom J Gastroenterol; 2005 Mar; 14(1):99-100; author reply 100. PubMed ID: 15800703
    [No Abstract]   [Full Text] [Related]  

  • 5. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.
    Dinesen L; Caspary WF; Chapman RW; Dietrich CF; Sarrazin C; Braden B
    Dig Liver Dis; 2008 Sep; 40(9):743-8. PubMed ID: 18339592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India.
    Hissar SS; Kumar M; Tyagi P; Goyal A; Suneetha PV; Agarwal S; Rastogi A; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2009 Apr; 24(4):581-7. PubMed ID: 19032460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.
    Leandro G; Mangia A; Hui J; Fabris P; Rubbia-Brandt L; Colloredo G; Adinolfi LE; Asselah T; Jonsson JR; Smedile A; Terrault N; Pazienza V; Giordani MT; Giostra E; Sonzogni A; Ruggiero G; Marcellin P; Powell EE; George J; Negro F;
    Gastroenterology; 2006 May; 130(6):1636-42. PubMed ID: 16697727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SEN virus infection influences the pathological findings in liver but does not affect the incidence of hepatocellular carcinoma in patients with chronic hepatitis C and liver cirrhosis.
    Moriyama M; Mikuni M; Matsumura H; Nakamura H; Oshiro S; Aoki H; Shimizu T; Yamagami H; Shioda A; Kaneko M; Tanaka N; Arakawa Y
    Liver Int; 2005 Apr; 25(2):226-35. PubMed ID: 15780043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C.
    Huang H; Shiffman ML; Cheung RC; Layden TJ; Friedman S; Abar OT; Yee L; Chokkalingam AP; Schrodi SJ; Chan J; Catanese JJ; Leong DU; Ross D; Hu X; Monto A; McAllister LB; Broder S; White T; Sninsky JJ; Wright TL
    Gastroenterology; 2006 May; 130(6):1679-87. PubMed ID: 16697732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of metabolic syndrome in the setting of chronic hepatitis C virus infection.
    Hanouneh IA; Feldstein AE; Lopez R; Yerian L; Pillai A; Zein CO; Zein NN
    Clin Gastroenterol Hepatol; 2008 May; 6(5):584-9. PubMed ID: 18455698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should trichrome stain be used on all post-liver transplant biopsies with hepatitis C virus infection to estimate the fibrosis score?
    Tretheway D; Jain A; LaPoint R; Sharma R; Orloff M; Milot P; Bozorgzadeh A; Ryan C
    Liver Transpl; 2008 May; 14(5):695-700. PubMed ID: 18324621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative assessment of fibrosis in liver biopsies from patients with chronic hepatitis B.
    Hui AY; Liew CT; Go MY; Chim AM; Chan HL; Leung NW; Sung JJ
    Liver Int; 2004 Dec; 24(6):611-8. PubMed ID: 15566512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of hepatic steatosis on the natural history of chronic hepatitis C infection.
    Cross TJ; Quaglia A; Hughes S; Joshi D; Harrison PM
    J Viral Hepat; 2009 Jul; 16(7):492-9. PubMed ID: 19200134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keratin variants associate with progression of fibrosis during chronic hepatitis C infection.
    Strnad P; Lienau TC; Tao GZ; Lazzeroni LC; Stickel F; Schuppan D; Omary MB
    Hepatology; 2006 Jun; 43(6):1354-63. PubMed ID: 16729313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of diabetes mellitus on prognosis of patients infected with hepatitis C virus.
    Kita Y; Mizukoshi E; Takamura T; Sakurai M; Takata Y; Arai K; Yamashita T; Nakamoto Y; Kaneko S
    Metabolism; 2007 Dec; 56(12):1682-8. PubMed ID: 17998021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease progression in Chinese chronic hepatitis C patients with persistently normal alanine aminotransaminase levels.
    Hui CK; Zhang HY; Shek T; Yao H; Yueng YH; Leung KW; Lai ST; Lai JY; Leung N; Lau GK
    Aliment Pharmacol Ther; 2007 Jun; 25(11):1283-92. PubMed ID: 17509096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FIB-4: a simple, inexpensive and accurate marker of fibrosis in HCV-infected patients.
    Vallet-Pichard A; Mallet V; Pol S
    Hepatology; 2006 Sep; 44(3):769; author reply 769-70. PubMed ID: 16941681
    [No Abstract]   [Full Text] [Related]  

  • 19. A multivariable model of clinical variables predicts advanced fibrosis in chronic hepatitis C.
    Alsatie M; Kwo PY; Gingerich JR; Qi R; Eckert G; Cummings OW; Imperiale TF
    J Clin Gastroenterol; 2007 Apr; 41(4):416-21. PubMed ID: 17413613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
    Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
    Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.